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Abstract 
Single-cell RNA sequencing (scRNA-seq) has become an established and powerful method to 
investigate transcriptomic cell-to-cell variation, revealing new cell types, and providing insights 
into developmental processes and transcriptional stochasticity. A key question is how the variety 
of available protocols compare in terms of their ability to detect and accurately quantify gene 
expression. Here, we assess protocol sensitivity and accuracy on many published data sets 
based on spike-in standards and uniform data processing, which includes the development of a 
flexible Unique Molecular Identifier counting tool (https://github.com/vals/umis). We compare 15 
protocols computationally and 4 protocols experimentally on batch-matched cell populations, in 
addition to investigating the impact of spike-in molecule degradation. Our analysis provides an 
integrated framework for comparing scRNA-seq protocols.  
Introduction 
The recent explosion in the development of protocols for sequencing the RNA of individual 
cells1,2 has generated different approaches to capture cells, amplify cDNA, minimise biases, and 
utilise liquid handling platforms. Due to the tiny amount of starting material, considerable 
amplification is an integral step of all of these protocols. Consequently, it is important to assess 
the sensitivity and accuracy of the protocols in terms of numbers of RNA molecules detected. 
Previous studies have compared the performance of a limited number of protocols 
experimentally3,4. In this study, we assessed the performance of a large number of published 
scRNA-seq protocols based on their ability to quantify the expression of spike-in RNA of known 
concentration. 
We define the sensitivity of a method as the minimum number of input RNA molecules required 
for a spike-in to be confidently detected (also known as the lower molecular detection limit, for a 
given sequencing depth), and accuracy as how close estimated relative abundances are to the 
known abundances of input molecules. High sensitivity permits the detection of very lowly 
expressed genes, while high accuracy implies that detected variations in expression reflect true 
biological differences in mRNA abundance across cells, rather than technical factors. 
The ERCC (External RNA Controls Consortium)5 spike-in standards consist of a mixture of 92 
RNA species of varying length and GC content, present at 22 abundance levels spaced one 
fold-change apart from each other (Supplementary Fig. 1). Such spike-ins have been used to 
assess the reproducibility of standard RNA-seq protocols6 and to judge the performance of 
differential expression tests on RNA-seq data7. In the context of scRNA-seq, ERCC spike-ins 
were first used with the CEL-seq protocol8. Here, we exploit spike-ins as a unified framework to 
compare the technical sensitivity and accuracy of different scRNA-seq protocol across various 
platforms, independent of the biological cell type investigated (Fig. 1). 
Our analysis is subject to limitations (explored in depth in the Discussion). We rely on accurate 
reporting of spike-in volumes and dilutions by the original authors, which we have reconfirmed in 
a few cases by personal communication. In addition, spike-in molecules may not truly reflect 
endogenous mRNA capture efficiency in scRNA-seq owing to deviation from natural mRNA 
sequence features such as shorter polyA tails and the absence of mRNA binding proteins. 
Nevertheless, our approach allows us to compare the large number of protocols and platforms 
with published spike-in data, most of which are replicated across at least two different cell types 
and different laboratories (Supplementary Table 1). This reduces potential bias due to a specific 
cell type or study. 
Results 
Our analysis spans 15 distinct experimental protocols encompassing 28 single-cell studies, 
including 17 studies that measured expression using full-length transcript coverage and 11 that 
used UMIs for digital quantification (Supplementary Table 1 and Online Methods). We also 
carried out 3 different scRNA-seq protocols on the Fluidigm C1 platform using batch-matched 
mouse embryonic stem cells (mESCs) with both ERCC and Spike-in RNA Variant (SIRV) spike-
ins (Online Methods). SMARTer and Smart-Seq2 were performed in duplicate and STRT-seq 
was performed once. We also generated a high throughput droplet-based 10X Genomics 
Chromium dataset on ERCC spike-ins and human brain total RNA. In total, our analysis covers 
18,123 publicly available samples comprising 30x109 sequencing reads. 
Using reported spike-in dilutions and volumes (Supplementary Table 1), we could calculate the 
absolute number of spike-in RNA molecules at different abundance levels across individual cell 
samples, thus permitting all data sets to be compared on the same scale. 
scRNA-seq quantification accuracy 
To assess the quantification accuracy of different protocols, we computed the Pearson product-
moment correlation coefficient (𝑅) between log transformed values of estimated ERCC RNA 
expression and input concentration for each individual cell or sample (Fig. 2A).  
Conventional bulk RNA-sequencing is more accurate than scRNA-seq protocols. Remarkably, 
the accuracy of scRNA-seq protocols is still high, and rarely do individual samples have a 
Pearson correlation lower than 0.6. The lower accuracy and variable Pearson correlations for 
individual cells within some protocols (GnT-Seq, CEL-Seq, MARS-Seq) may indicate variable 
success rates for these protocols. 
scRNA-seq sensitivity 
To investigate the technical sensitivity achieved for each sample and quantify inter-sample 
variability for each protocol, we devised a logistic regression model with detection of expression 
as the dependant variable. Our measure of sensitivity is the spike-in input level at which the 
probability of detection reaches 50% (Fig. 1b). Measuring the sensitivity of each sample 
individually avoids biases due to uneven batch sizes. It also avoids using detected spike-ins 
ratios at each abundance level, which would give poor resolution, because no more than seven 
spike-ins share one abundance level.  
scRNA-seq protocols are more sensitive than bulk RNA-seq and can detect very low numbers 
of input molecules (Fig. 2B). The sensitivity of scRNA-seq protocols varied over four orders of 
magnitude, and several protocols have the potential to detect as little as single digit input spike-
in molecules (SMARTer (C1), CEL-Seq2 (C1), STRT-Seq, and inDrop). We observe high within-
protocol variability in sensitivity, which can be attributed to sequencing depth; we quantify this in 
a section below to rank the protocols. 
UMI efficiency in tag-counting protocols 
The majority of scRNA-seq protocols utilise an UMI-tag counting strategy, in which a single 
unique random identifier sequence is added to each reverse transcribed mRNA molecule in 
order to achieve digital transcript quantification. This strategy has largely been applied to 
protocols that sequence short 5’ or 3’ RNA sequence tags and thus create cDNA libraries with 
extremely low complexity, which may lead to strong amplification biases. The UMI on each tag 
should allow one to remove these biases, as it is added prior to amplification9. The question 
then remains as to how efficient the entire scRNA-seq process is. 
If 𝑅 is the UMI (counting) efficiency, the underlying assumption is that the number of UMIs of a 
gene 𝑅 = 𝑅 ⋅ 𝑅, where 0 < 𝑅 < 1 (Supplementary Fig. 2A) and 𝑅 is the number of RNA 
molecules of a gene. We fitted this model for every UMI-tag sample and compared the results 
across protocols (Fig. 2C). The results recapitulate the logistic regression based measure for 
sensitivity, as samples with high efficiency have a low molecule detection limit (with the 
exception of MARS-Seq data, Supplementary Fig. 2B).  
However, this measure might not be as appropriate as it appears. If we extend the model to 𝑅 =
𝑅 ⋅ 𝑅𝑅, the best fit should give values of the molecular exponent 𝑅 close to 1, if the underlying 
UMI counting assumption is correct. Instead, we find that the best fit is systematically lower than 
1, with a mode of around 0.8 (Supplementary Fig. 2C). This implies a saturation of UMI counts 
as a function of input molecules. This can be explained partially (but not fully) by differences in 
UMI length between the different protocols (Supplementary Fig. 2D). For example, UMIs with 
length of 4 base pairs can only count up to 256 unique molecules, and have on average a 
molecular exponent of 0.6. However, even in protocols with UMIs of 10 base pairs (which can 
count over a million unique molecules), the molecular exponent is 0.8 per sample on average, 
and rarely reaches 1.  
In conclusion, while UMIs should provide a way of removing amplification biases, the assumed 
absolute quantification does not seem to hold perfectly. 
Endogenous transcripts are more efficiently captured than ERCC spike-ins 
It is unclear to what extent sensitivity and accuracy calculations based on exogenous spike-ins 
apply to endogenous mRNA. On the one hand, ERCC spike-ins have shorter poly(A) tails than 
typical mRNA from mammalian cells10, making them harder to capture by poly(T) priming. On 
the other hand, endogenous mRNA may have intricate secondary structure and can be bound 
to proteins, potentially reducing the efficiency of reverse transcription.  
To investigate the relationship between endogenous and spike-in measurements, we analysed 
single molecule fluorescent in-situ hybridization (smFISH) data and CEL-seq data from the 
same mESC line and culture conditions11 (molecule counts from Dominic Grün, personal 
communication). Based on data for 9 endogenous genes, CEL-Seq UMI counts correspond to 
5-10% of smFISH counts, whereas average UMI counts for ERCC transcripts correspond to 
only 0.5-1% of input molecule counts (Supplementary Fig. 2E). 
Although the number of transcripts is not large, this data suggests that endogenous RNA is 
much more efficiently captured and amplified than ERCC spike-in molecules, and that our 
sensitivity measures are likely to be underestimates. The accuracy metric is based on relative 
abundances, and is not affected by this. This difference in efficiency is important to consider if 
absolute molecule counts are to be inferred based on ERCC spike-ins.  
Sensitivity is more dependent on sequencing depth than accuracy 
The results of the per-sample accuracy and sensitivity analysis shows a large amount of within-
protocol heterogeneity (Fig. 2A-B). Seeking to explain performance by technical factors, we find 
a relation with sequencing depth per sample, which researchers can control to fit their budgets 
and needs. We used a linear model that considers a global effect of sequencing depth, including 
diminishing returns (Online Methods). The model includes an individual corrected performance 
parameter for each protocol, which allows protocols to be ranked while accounting for the 
substantial technical factor of sequencing depth. 
We find that accuracy does not strongly depend on sequencing depth (Fig. 3A). The best 
performing protocols in terms of accuracy are SUPeR-Seq (𝑅=0.95), a total-RNA protocol for 
single cells, and CEL-Seq2 (𝑅=0.94), which uses In Vitro Transcription (IVT) rather than PCR to 
amplify cDNA. 
Since the model considers diminishing returns on the sequencing depth, we can identify from 
the model parameters that accuracy becomes saturated at as few as 250,000 reads, illustrating 
that it is not strongly dependent on sequencing depth. This also suggests that the expression 
levels of detected RNAs are generally accurate and quantitatively meaningful in scRNA-seq 
data. 
By contrast, we find that technical sensitivity is critically dependent on sequencing depth, and 
sensitivity comparisons that do not account for differences in depth would be misleading (Fig. 
3B). The sensitivity parameter of the model accounts for sequencing depth to allow for fair 
comparison, and we used this to rank protocols. The three protocols implemented in a C1 
microfluidics system (CEL-Seq2 (C1), STRT-Seq (C1), and SMARTer (C1); number of 
molecules at a million reads, #𝑅 = 2, 3 and 4 respectively) were the top performing protocols in 
terms of molecule detection. The matched microwell plate implementation of CEL-Seq2 has 
poorer sensitivity than the C1 implementation (#𝑅 = 13). 
Based on the model, we find that sensitivity saturates at about 4.5 million reads per sample. The 
increase in read depth from 1 million reads to 4.5 million reads per sample results in marginally 
increased sensitivity; less than a fold change. However the increase from 100,000 reads to 1 
million reads per sample results in increased sensitivity of an order of magnitude. Thus, we 
recommend considering 1 million reads per sample as a good target for saturated gene 
detection. 
It should be noted that not all studies need to saturate detection, especially in cases where the 
genes of interest are highly expressed. It is equally important to note that sequencing depth is a 
technical feature, and the number of genes detected depend on the depth. Therefore, 
sequencing depth must be taken into account when performing and computationally analyzing 
scRNA-seq, even for compositional expression units such as TPM (Transcripts Per Million). 
Degradation of spike-ins does not explain performance variation between 
experiments 
Our performance analysis inherently assumes the gold standard annotation of the spike-ins to 
be correct. However, due to the labile nature of RNA, it can get degraded during the course of 
normal reagent handling. To quantify the impact of degradation, we subjected spike-in 
molecules (both ERCCs and SIRVs) to repeated freeze-thaw cycles (Online Methods). 
Additionally, as a measure of complete/full degradation, we left the spike-ins either at room 
temperature or at 37°C overnight. The freeze-thaw cycles emulate normal handling and upon 
comparing these to our in-house protocols, we observed an overall small effect on accuracy, 
which was similar between protocols (Fig. 4A).  
Spike-in degradation directly impinges on the effective spike-in dilution in a sample, which is a 
central factor for calculating the technical sensitivity. We observed that normal handling 
accounts for molecule limit differences within an order of magnitude, even when spike-ins are 
subjected to as many as six freeze-thaw cycles. The sensitivity metric for samples subjected to 
conditions as extreme as overnight degradation (room temperature or 37°C) had two orders of 
magnitude difference compared to other samples, similar to the difference between protocols 
(Fig. 4A). 
SIRV spike-ins recapitulate accuracy results based on ERCC spike-ins 
All the studies mentioned above are based on the ERCC spike-ins, which have bacterial 
sequence composition. To ensure that our conclusions are generally applicable, we also 
analysed the SIRV spike-in mix, consisting of 69 artificial transcripts that mimic the splicing 
patterns of 7 human genes and allow RNA isoform assessment. The SIRV mix E2 contains 
these isoforms across four abundance levels. As SIRVs only span four abundance levels, they 
are not compatible with sensitivity analysis, so we focused on accuracy. To compare accuracy 
using ERCC and SIRV standards, we performed two matched scRNA-seq comparisons (Smart-
seq2, SMARTer and STRT-seq on C1 system) using mESCs with both spike-ins (Fig. 4b).  
We observe that accuracy is systematically lower when using SIRVs. This is expected, since the 
ambiguous read assignment to the isoforms introduces a noise element. Overall, we observed a 
similar pattern of relative accuracy based on SIRVs and ERCCs between our SMARTer and 
Smart-Seq2 experiments. The STRT-Seq samples had very poor accuracy, as expected since 
the 5’ transcript tags alone cannot distinguish between different mRNA isoforms.  
This experiment provides quantitative evidence that mRNA splice form variation can be inferred 
at the single cell level using the appropriate protocol. Comparing the protocols, accuracy 
calculated based on SIRVs recapitulates accuracy based on ERCCs, indicating that spike-in 
batch variability does not in general explain differences between protocols. 
Endogenous mRNA amount does not affect performance metrics based on 
spike-ins 
cDNA is generated from both endogenous mRNA and spike-in RNA during library preparation; 
thus, spike-ins are less likely to be sampled if the amount of mRNA is higher. To verify that 
discrepancy in endogenous mRNA levels (due to e.g. cell type differences) does not affect 
performance metrics, we investigated published data where information on empty (spike-in RNA 
alone) and non-empty (mRNA and spike-ins present) samples was provided for the same batch 
of cells. We compared accuracy and sensitivity between empty and non-empty samples from 
three studies and found equivalent results, confirming that endogenous mRNA content does not 
affect performance metrics (Fig. 4C). We quantified the equivalence using 95% Confidence 
Interval (CI) based equivalence analysis12 (Online Methods). We found that the empty median 
CI is 100% contained within the non-empty median CI for accuracy, and 84% contained for 
sensitivity.  
Impact of freeze-thaw cycles on spike-in abundance 
To quantify RNA degradation rates in our freeze-thaw experiment, we added single mESCs to 
individual wells and performed the Smart-seq2 protocol. We compared the spike-in content to 
the endogenous mRNA content within each well, and related this to the number of freeze-thaw 
cycles.  
We made a predictive Bayesian model of mRNA degradation (see Online Methods) with a 
degradation rate parameter 𝑅. Sampling from the posterior distribution of 𝑅 when applying the 
model to ERCC spike-ins, we found a degradation rate of 19±0.7% per freeze-thaw cycle (95% 
CI, Supplementary Fig. 3, see Fig. 4d for posterior predictions). We also applied the mRNA 
degradation model to SIRVs, and found a similar degradation rate of 18.5±0.1%. However, the 
SIRV measurements were more noisy, likely due to mapping uncertainty (see Discussion). 
Overall, our data approximates a 20% degradation rate of spike-ins in each freeze-thaw cycle 
during normal sample handling. 
While we did not observe a large variation in molecular detection limit or accuracy due to normal 
handling, the relative abundance of spike-ins in a sample is strongly affected by freeze-thaw 
cycles. This means that the inference of total mRNA in cells based on spike-ins might prove 
problematic. As we also found that the degradation rate was conserved between ERCC and 
SIRV spike-ins, the approximately 20% degradation rate per freeze-thaw cycle may hold for 
RNA in general. 
Discussion 
A previous study showed13 that ERCC read alignment varies widely between libraries and 
platforms, with some spike-ins having reproducibly poor behavior. This raises the question of 
whether spike-ins are suitable for the calibration of absolute expression values. The ERCC 
spike-ins have short poly-A tails ranging from 20 to 26 bases long (the majority are 24 bases) in 
comparison to eukaryotic mRNAs of 250 base long poly-A tails10. This suggests that poly-T 
priming of ERCC spike-ins might be less efficient than for endogenous mRNA. Furthermore, 
ERCC spike-ins are not capped at the 5’ end, which may lead to reduced template switching 
efficiency (used in several protocols) as compared to endogenous mRNAs14. Lastly, unlike 
endogenous mRNAs, spike-in RNA are not naturally bound by mRNA-binding proteins or have 
secondary structures. 
Our comparison of smFISH values, a gold standard for absolute mRNA quantification, with 
spike-in values, suggests that endogenous RNA is detected more efficiently than spike-ins by 
about one order of magnitude. Therefore, it is important to highlight that the “spike-in molecule 
detection limit” may underestimate the detection limit for endogenous RNA, and should only be 
used as a relative sensitivity measure to rank protocols. The global ranking of protocol 
sensitivity remains relevant, and accuracy is unaffected by these issues, as all ERCC spike-ins 
within a sample are equally affected. 
A perfect comparison would implement each protocol in multiple laboratories using a single 
stock of reagents and mRNA dilution ladders as standards. Having multiple scientists carry out 
each protocol would allow the effects of skill to be excluded. A control ladder of mRNA would 
eliminate issues arising from differences between synthetic spike-ins and mRNA. While the 
majority of the protocols we have investigated here have been reproduced by at least two 
distinct laboratories (Supplementary Table 1), we cannot completely rule out the impact of 
technical proficiency on protocol performance. 
We showed that handling and batch variation in ERCC dilutions leads to smaller variations in 
performance than we see between protocols (Fig. 4A). Nevertheless, in certain published 
experiments, spike-ins may have been greatly degraded with an impact on our performance 
metrics. In addition to these caveats, it is important to note that our assessment was performed 
on currently available data, and does not necessarily reflect the full potential or suitability of a 
given protocol. 
The scRNA-seq protocols that we analyzed provide tremendously powerful and high resolution 
techniques for unbiased genome-wide dissection of cell populations and their transcriptional 
regulation. We show that while these protocols vary widely in their detection sensitivity, with 
lower limits between 1 and 1,000 molecules per cell, their accuracy in quantification of gene 
expression is generally high. Sensitivity depends on sequencing depth, but this is less critical for 
accuracy. However, both sensitivity and accuracy are closely dependent on the scRNA-seq 
protocol used to generate the data. Protocols with high sensitivity are more suitable for 
analyzing lowly expressed genes or for additional insights into more subtle gene expression 
differences affecting individual cell states, but may be less suitable for other scenarios. 
Our comparison also suggests that miniaturized scRNA-seq reaction volumes increase 
sensitivity and provide a good return on investment when sequencing around a million reads per 
sample. Future improvements of protocols and decreases in the price of sequencing will further 
boost our ability to answer new questions in biology using single cell transcriptomics. 
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Fig. legends 
Fig. 1 
Strategy for scRNA-seq protocol comparison.  
(a) Endogenous mRNA levels vary by cell type and condition and cannot be used to compare 
protocols applied to different cell types. By contrast, protocols can be compared, regardless of 
cell type, by measuring the same spike-in RNA standards added at known concentrations to all 
experiments. (b,c) We define two global technical performance metrics based on spike-ins: (b) 
Sensitivity, the number of input spike-in molecules at the point where the probability of detection 
reaches 50%, and (c) Accuracy, the Pearson product-moment correlation (𝑅) between 
estimated expression levels and actual input RNA molecule concentration (ground truth). 
Fig. 2 
Performance metrics for scRNA-seq protocols.  
(A) Accuracy. Distributions of Pearson correlations (𝑅) for all samples stratified by protocol 
(without accounting for sequencing depth). (B) Sensitivity. Distributions of molecule detection 
limits for all samples stratified by protocol (without accounting for sequencing depth). n, number 
of samples. The implementation platforms and quantification strategies are indicated below the 
protocols. (C) UMI Efficiency. Distributions of UMI counting efficiencies in UMI-tag counting 
based samples, stratified by protocol. 
Fig. 3 
Performance metrics after accounting for sequencing depth.  
(a,b) Models of accuracy and sensitivity with a global dependency on sequencing depth 
considering diminishing returns, with a distinct corrected performance parameter for each 
protocol. Each model has 26 parameters, and is fitted to n=20,717 samples. Bulk data (pink 
triangles) are only displayed for context. Solid curves show the predicted dependence on 
sequencing depth. (A) Accuracy is only marginally dependent on sequencing depth. Saturation 
occurs at 270,000 reads per cell in the model (dashed red line). Protocol names are ordered by 
performance based on predicted correlation 𝑅 at 1 million reads. (B) Sensitivity is critically 
dependent on sequencing depth. Saturation occurs at 4.6 million reads per cell (dashed red 
line). The gain from 1 to 4 million reads per sample is marginal, while we note that moving from 
100,000 reads to 1 millions reads corresponds to an order of magnitude gain in sensitivity 
(dashed black lines). Protocols are ordered by performance based on predicted detection limit 
(#𝑅, number of molecules at 1 million reads). 
Fig. 4 
Impact of various factors on performance metrics.  
(A) Batch effects and RNA degradation. Performance distributions for three protocols 
implemented as a single batch, on the Fluidigm C1 (left) and 10x Chromium (far-left; different 
batch) platforms. Performance distributions of spike-ins measured after freeze-thaw cycles, 
normal (2-3 cycles) to critical degradation (6 cycles, left overnight at room temperature). (B) 
Accuracy estimates across both ERCC and SIRV spike-ins are similar. Accuracy (Pearson 
correlation) of both ERCC and SIRV spike-ins inferred across two replicates using multiple 
protocols. (C) Endogenous mRNA amount does not affect performance metrics. 
Comparison of performance metrics between empty (lacking endogenous mRNA) and non-
empty samples from 3 published datasets shows similar performance and no bias due to 
presence of endogenous mRNA. Red dot, median. Red bar, 95% CI of median, estimated with 
bootstraps. (D) Model of relative spike-in abundance degradation during normal handling. 
Posterior predictions from Bayesian exponential decay model, for both ERCCs and SIRVs 
(decay parameter 19% and 18.5%, respectively). Confidence bands correspond to 95% CI from 
posterior parameter distribution. 
Online Methods 
Mouse embryonic stem cell culture 
Wildtype E14 mouse ES cells (kindly provided by Pentao Liu, Wellcome Trust Sanger Institute) 
were cultured on gelatin coated dishes using Knockout DMEM (#10829; Gibco), 15% Fetal Calf 
Serum (FB-1001/500; batch tested from Labtech), 1x Penicillin-Streptomycin-Glutamine 
(#10378-016; Gibco), 1x MEM NEAA (11140-035; Gibco), 2-mercaptoethanol (31350-010; 
Gibco) and 1000U Leukemia Inhibitory Factor (LIF; #ESG1107). Mycoplasma-free tested mESC 
were passaged every 2-3 days. 
SMARTer, Smart-Seq2 and STRT-Seq on C1 
E14 mESCs were trypsinized to obtain single cell suspension and passed through 30µm filter 
(CellTrics; #04-0042-2316). Cells were processed using the C1 Single Cell Auto Prep System 
(Fluidigm; #100-7000 and #100-6209) following the manufacturers protocol (#100-5950 B1). 
Briefly, we perform SMARTer, Smart-seq2 and STRT-Seq each across three small C1 Open 
App IFCs (5-10µm; #100- 5759). The specific sample preparation steps for the three protocols 
(SMARTer3,28,29,31,32, Smart-seq240 and STRT-Seq9,11,20,23) were downloaded from Fluidigm 
Script Hub. Dissociated single cells were loaded and captured on C1 Open App IFCs, followed 
by manual inspection to demarcate empty well, doublets or debris containing wells. Two 
different spike-in RNA control sets were used for batch-matched comparison of different 
protocols, 92 ERCC spike-ins (#4456740; Lot# 1411014; Ambion) and 69 SIRV spike-ins 
(#SKU025.03; E2 Spike-in RNA Variant Control Mixes; Lexogen), were mixed (0.5µl 1:500 
diluted ERCCs + 0.6µl 1:500 diluted SIRVs) and added to respective lysis buffer master mixes 
for SMARTer (20μl), Smart-Seq2 (27μl) and STRT-seq (20μl). 9μl of the respective lysis master 
mix is added to each Open App C1 IFCs. The subsequent steps (cell lysis, cDNA synthesis by 
reverse transcription and PCR reaction) are performed as described on Fluidigm Script Hub.  
SMARTer and Smart-Seq2 on C1 
E14 mESCs were trypsinized to obtain single cell suspension and passed through 30µm filter 
(CellTrics; #04-0042-2316). Single cell suspension was processed using SMARTer and Smart-
seq2 in parallel across two C1 Single Cell Auto Prep System (Fluidigm; #100-7000 and #100-
6209) following the manufacturer's protocol (#100-5950 B1). Smart-seq2 protocol was 
downloaded from Fluidigm Script Hub. The cells were loaded, captured on C1 Open App IFCs, 
followed by manually inspection. Both ERCC and SIRV spike-ins were mixed (0.5µl 1:500 
diluted ERCCs + 0.6µl 1:500 diluted SIRVs) and added to respective Lysis buffer master mixes 
for SMARTer (20μl) and Smart-Seq2 (27μl). The subsequent steps (cell lysis, cDNA synthesis 
by reverse transcription and PCR reaction) are performed as described on Fluidigm Script Hub. 
Spike-in degradation experiment using Smart-Seq2 on plates 
We used new tube of Spike-ins, ERCC (#4456740; Lot# 1412014; Ambion) and SIRV (E2 mix; 
#SKU025.03; Lot#216651530; Lexogen) for this experiment. Briefly, 1:100 dilutions of ERCCs 
and SIRVs were mixed together resulting in spike-in master mix (1:200 final dilution; termed ‘x2 
Freeze-thaw’). The spike-in master mix was split between three tubes; one left overnight at 
37°C (Condition 1), one left overnight at room temperature (Condition 2) and third kept overnight 
at -80°C. The following day the third tube (from -80°C) was subjected to multiple freeze-thaw 
cycle wherein the tube was thawed at room temperature for 2-5minutes, an aliquot was taken 
and re-freezed in dry ice. We repeated this freeze-thaw cycle an additional 5 times (Condition 3 
to Condition 7). All the spike-in mixes (Condition 1-7) were subsequently diluted to a final 
1:1000,000 dilution. A 96-well plate for Smart-seq2 was prepared by dispensing 2 μl Smart-
Seq2 lysis buffer (0.2%Triton, 1:20 RNAse inhibitor, 10mM Oligo-dT30VN, 10mM dNTPs) across 
each well. 1µl of spike-in mix per condition (Condition 1-7) was added to each well column-wise 
such that each column represented a single condition with 8 replicate wells. E14 mESCs were 
filtered through a 30µm filter and FACS sorted (BD Influx; BD Biosciences) into 96-well plate. 
The first three wells (row-wise) across the 96-well plate received matched bulk 500, 50 and 5 
cells, and all other wells received a single cell. The 96-well plate was immediately spun and 
frozen on dry-ice prior to Smart-seq2 protocol as previously described40. 
Library preparation and Sequencing 
Representative cDNA from single cells across three C1 runs and Smart-Seq2 (on plates) were 
assessed using High Sensitivity DNA chips for Bioanalyzer (5067-4626 and 5067-4627; Agilent 
Technologies). Single cell cDNA from SMARTer3,28,29,31,32 and Smart-Seq2 C1 IFCs and Smart-
seq2 (on plates) was tagmented and pooled to make libraries using Illumina Nextera XT DNA 
sample preparation kit (Illumina; FC-131-1096) with 96 dual barcoded indices (Illumina; FC-131-
1002). The library clean-up and sample pooling was performed using AMPure XP beads 
(Agencourt Biosciences; A63880). All protocols are described in the Fluidigm protocol (100-
5950), Fluidigm Script Hub and Smart-seq2 protocol40. The STRT-Seq libraries were made and 
sequenced at Karolinska Institutet as previously described9,20. The Single cell libraries from 
SMARTer and Smart-Seq2 C1 IFCs and Smart-seq2 (on plates) was sequenced across 1 lane 
of HiSeq V4 (Illumina) using 75bp/125bp paired-end sequencing.  
10x Genomics Chromium experiment 
The Single Cell Gel Bead kit (#120217), Single cell chip kit (#120219) and Single cell library kit 
(#120218) were used along with 10x GemCode Single Cell Instrument as per manufacturer 
specifications and manuals (Document # CG00011; Revision B). Equal volumes of control brain 
RNA (3µl; FirstChoice Human Brain Total RNA; #AM7962) and ERCC spikes (3µl 1:4 dilution; 
#4456653) were mixed to form a ‘2x Control RNA+ERCC’ master mix. We further diluted this to 
‘1x Control RNA+ERCC’ with PCR grade water. We made two single cell master mix 
preparation using 3µl of ‘2x Control RNA+ERCC’ and ‘1x Control RNA+ERCC’ respectively 
instead of single cell suspension (adjusted with 34.4 µl Nuclease-Free water). The remaining 
protocol was followed as per manufacturer's manual (Document # CG00011; Revision B). Each 
10x library was sequenced across HiSeq2500 (2x lanes; Rapid Run) as per Wellcome Trust 
Sanger Institute sequencing guidelines. 
Data Sources 
Raw read data from published studies was downloaded from either ENA or SRA, as listed with 
accession numbers in Supplementary Table 1. Information regarding concentration and volume 
of ERCC mix in each sample was gathered from the original publications (also indicated in 
Supplementary Table 1) or through direct communication with authors in ambiguous cases. 
The expression table for mESC-STRT had non-standard names annotating the ERCC spike-ins, 
and through personal communication with the authors we were given a table for converting 
these to the names as provided by Life Technologies. Additionally we were informed by the 
authors that the final spike-in dilution noted as 1:50000 in Islam et al9 had actually been 
1:20000. 
The concentrations of the ERCC solution in the Dendritic-MARS table was ambiguous as there 
were two different values in the GEO table and in the text of the paper. Communication with the 
authors clarified that these referred to different volumes. The volume and dilution described in 
the GEO table was used. Thirty samples were excluded as they were annotated as not having 
had ERCC spike-ins added to them. 
For the K562-SMART data it was unclear which data sets had used spike-ins, and personal 
communication with the authors provided the names of the two batches which had spike-ins 
added. 
A table with notes on individual data sets is provided (Supplementary Table 1). 
RNA-Seq data processing 
For coverage based data, relative abundances were quantified using Salmon41 0.6.0, with 
library type parameter -l IU and the optional flag --biasCorrect. The Salmon transcriptome 
indices were built by adding ERCC sequences to cDNA sequences from Ensembl. For samples 
with mouse background, this was Ensembl 83 cDNA annotation of GRCm38.p4. For samples 
with human background, this was cDNA annotation from Ensembl 78 of GRCh38, and for 
samples with zebrafish background, the Ensembl 77 annotation of Zv9. Finally, for samples with 
frog background, this was Ensembl 84 annotation of JGI4.2. 
All coverage-based datasets were sequenced using Illumina paired-end sequencing, with read 
lengths between 75 and 150 base pairs. 
In order to process all UMI-based data in a coherent way, we developed a quantification 
strategy based on pseudo-mapping, and counting up evidence for (transcript, UMI) pairs.  
The principle is to transfer information from a (UMI, tag) pair to a (transcript, UMI) pair based on 
which transcript the tag maps to. Since UMI-based methods only use 3’ or 5’ end tags of cDNA, 
which can be as short as 25bp, mapping of these tags are commonly ambiguous. Our strategy 
for this is to weight a (UMI, tag) pair by the number of transcripts the tag maps to. After (UMI, 
tag) pairs were mapped with either RapMap42 or Kallisto43 in pseudobam mode, only (transcript, 
UMI) pairs with a user specified minimum amount of evidence are counted (default 1). This can 
be either on the gene or transcript level. In the 10x Genomics Chromium data we detected 
70,000 and 45,000 droplets with respect to the samples. For the sake of computational memory 
efficiency we uniformly sampled 2000 droplets out of all detected droplets to count the umi tags 
per droplet. 
Code Availability 
We implemented the UMI counting strategy in a publicly available command line tool which we 
call ‘umis’. The tool as available at https://github.com/vals/umis/ as well as in the Python 
Package Index, and in Bioconda. Version 0.3.0, used for this paper, is submitted as 
Supplementary Software. 
Analysis 
An ERCC spike-in was considered detected when the estimated TPM of that ERCC was greater 
than zero. For UMI-based data, a spike-in is detected when at least one copy of an ERCC 
molecule is inferred. 
The amount of input spike-in molecules for each spike, for each sample, in each experiment 
was calculated from the final concentration of ERCC spike-in mix in the sample. 
Calculation of the accuracy of an individual sample was done by the Pearson correlation 
between input concentration of the spike-ins and the measured expression values. If less than 8 
spike-ins were observed, the accuracy was set to infinity, as we consider this to be insufficient 
evidence to estimate the accuracy. 
For the logistic regression model of each sample’s detection limit, the probability of detecting a 
spike-in at a given input level is modeled by the logistic function: 
𝑅(𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅)  =
1
1 + 𝑅−(𝑅⋅ 𝑅𝑅𝑅(𝑅𝑅)+𝑅)
+ 𝑅. 
We used the LogisticRegression class from the linear_model module of the machine learning 
package scikit-learn44. The fit was performed with the liblinear solver and the optional argument 
fit_intercept=True. The logistic regression analysis was limited to samples with at least eight 
spike-ins detected. The detection limit was chosen as the molecular abundance where the 
logistic regression model passes 50% detection probability: 
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑅𝑅𝑅𝑅𝑅 =  −
𝑅
𝑅
. 
To investigate the UMI efficiency of UMI based protocols, we used a linear model where the 
only parameter was the efficiency: 
𝑅𝑅𝑅𝑅 = 𝑅 ⋅ 𝑅𝑅 + 𝑅. 
As we mention in the text though, the data fits a model much better where there is a non-one 
exponent parameter on the number of input molecules: 
𝑅𝑅𝑅𝑅 = 𝑅 ⋅ 𝑅𝑅
𝑅 + 𝑅. 
When we model the relation between read depth and performance metrics for individual 
protocols, we use a linear model with a quadratic term for read depth to capture diminishing 
returns on investment. The model considers the read depth effect to be global, and has a 
categorical performance parameter for each protocol: 
𝑅𝑅𝑅𝑅𝑅𝑅𝑅 = 𝑅
2 ⋅ 𝑅𝑅𝑅10(𝑅𝑅𝑅𝑅𝑅𝑅) + 𝑅 ⋅ 𝑅𝑅𝑅10(𝑅𝑅𝑅𝑅𝑅𝑅) + 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅  +  𝑅. 
Here the performance metric will plateau and saturate when 
𝑅𝑅𝑅10(𝑅𝑅𝑅𝑅𝑅)  =  −
𝑅
2𝑅
. 
The linear models were fitted and analysed using the OLS regression function in the 
statsmodels Python package. 
In the spike-in degradation model the degradation rate p and the cellular fraction F were inferred 
by a Bayesian approach using Stan45 (R package rstan v 2.10.1). The model was specified as 
the following: p was sampled from a uniform distribution between 0 and 1, Fi for each spike-in i 
was drawn from a normal distribution with mean 0.5 and standard deviation 1. Fij was estimated 
by a normal distribution with mean Fi *(1-p)j, where j was the j-th freeze-thaw cycle and standard 
deviation sigma sampled from a uniform distribution between 0 and 20. The model was run with 
5000 iteration steps, 1000 warm up steps and 4 chains. 
Confidence intervals with regard to accuracy and sensitivity for non-empty and empty wells 
were estimated by bootstrapping. Therefore, study SRP055153, ERP010952 and SRP070989 
were pooled together separating non-empty and empty wells, respectively. For each group, 
sample sizes of 20 were randomly picked with replacement and median of the bootstrapped 
samples was determined. This process was repeated with a number of 1,000 iterations. Having 
sorted the bootstrapped estimates, we determined the median and the 2.5th and 97.5th 
percentiles of the distributions for non-empty and empty wells. All data needed for our analysis 
is provided as Supplementary Table 2. 
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